Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-12-021134
Filing Date
2012-04-23
Accepted
2012-04-23 16:04:29
Documents
1
Period of Report
2012-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6469
  Complete submission text file 0001140361-12-021134.txt   7907
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

EIN.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 500 PARK AVENUE NEW YORK NY 10022
Business Address
TISCH DANIEL R (Reporting) CIK: 0001111794 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 12773398